SciClone Pharmaceuticals, Inc. Share Price

Stocks

14/17/14	SciClone Pharmaceuticals : Consortium Led By GL Capital Completes Acquisition Of SciClone	PR
29/17/29	Levi & Korsinsky, LLP Notifies Shareholders of SciClone Pharmaceuticals, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of October 30, 2017	BU
18/17/18	Monteverde & Associates PC Announces An Investigation Of SciClone Pharmaceuticals, Inc. - SCLN	PR
16/17/16	SciClone Pharmaceuticals : Breakfast Technical Briefing on Drug Makers Stocks -- Depomed, Synergy Pharma, Novo Nordisk, and SciClone Pharma	PR
11/17/11	SciClone Pharmaceuticals : Announces End Of Go-Shop Period With No Parties Designated As Excluded Parties	PR

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SCICLONE PHARMACEUTICALS, INC.	-.--%	-.--%	-	-	0
ELI LILLY AND COMPANY	+1.93%	+3.85%	+51.05%	+166.24%	1,08900Cr
JOHNSON & JOHNSON	+0.29%	+6.43%	+60.47%	+52.87%	64TCr
ABBVIE INC.	+2.45%	+2.77%	+39.61%	+74.48%	47TCr
ROCHE HOLDING AG	+2.17%	+10.22%	+41.17%	+36.56%	36TCr
NOVARTIS AG	+1.46%	+3.87%	+39.70%	+44.49%	30TCr
ASTRAZENECA PLC	+0.40%	+3.59%	+19.93%	+17.02%	27TCr
NOVO NORDISK A/S	+2.73%	+3.50%	-25.66%	-36.53%	23TCr
AMGEN INC.	+4.48%	+7.33%	+30.47%	+66.31%	21TCr
GILEAD SCIENCES, INC.	+2.91%	+3.10%	+18.84%	+74.76%	17TCr
Average	+1.96%	+5.07%	+30.62%	+55.13%	41.46TCr
Weighted average by Cap.	+1.97%	+5.14%	+39.89%	+80.14%